Jefferies Group LLC raised its stake in Waters Co. (NYSE:WAT) by 1,121.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,143 shares of the medical instruments supplier’s stock after buying an additional 35,291 shares during the quarter. Jefferies Group LLC’s holdings in Waters were worth $6,258,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Marshall Wace LLP purchased a new stake in Waters during the second quarter worth about $239,000. Wells Fargo & Company MN increased its stake in Waters by 40.5% during the second quarter. Wells Fargo & Company MN now owns 336,181 shares of the medical instruments supplier’s stock worth $65,081,000 after purchasing an additional 96,866 shares during the period. Fundsmith Equity Fund L.P. purchased a new stake in Waters during the second quarter worth about $915,485,000. Ontario Teachers Pension Plan Board increased its stake in Waters by 62.9% during the second quarter. Ontario Teachers Pension Plan Board now owns 155,990 shares of the medical instruments supplier’s stock worth $30,198,000 after purchasing an additional 60,239 shares during the period. Finally, Mackay Shields LLC increased its stake in Waters by 50.2% during the second quarter. Mackay Shields LLC now owns 20,112 shares of the medical instruments supplier’s stock worth $3,894,000 after purchasing an additional 6,724 shares during the period. 98.51% of the stock is currently owned by institutional investors.

WAT has been the topic of a number of recent research reports. Barclays cut their price target on shares of Waters from $200.00 to $190.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 24th. Morgan Stanley boosted their price target on shares of Waters from $204.00 to $211.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 10th. Goldman Sachs Group lowered shares of Waters from a “neutral” rating to a “sell” rating and cut their price target for the stock from $185.00 to $180.00 in a research note on Friday, November 30th. Leerink Swann lowered shares of Waters from an “outperform” rating to a “market perform” rating in a research note on Monday, October 8th. Finally, UBS Group initiated coverage on shares of Waters in a research note on Tuesday, October 9th. They set a “neutral” rating and a $210.00 price target on the stock. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $205.07.

In other Waters news, Director Thomas P. Salice sold 3,500 shares of the stock in a transaction that occurred on Wednesday, October 31st. The shares were sold at an average price of $192.00, for a total value of $672,000.00. Following the transaction, the director now directly owns 20,911 shares in the company, valued at $4,014,912. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Christopher A. Kuebler sold 8,000 shares of the stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $199.67, for a total transaction of $1,597,360.00. Following the completion of the transaction, the director now owns 18,911 shares in the company, valued at $3,775,959.37. The disclosure for this sale can be found here. 0.98% of the stock is currently owned by corporate insiders.

WAT stock opened at $188.94 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 5.93 and a current ratio of 6.63. Waters Co. has a fifty-two week low of $167.93 and a fifty-two week high of $220.20. The company has a market cap of $14.69 billion, a P/E ratio of 24.33, a PEG ratio of 2.32 and a beta of 0.97.

Waters (NYSE:WAT) last released its earnings results on Tuesday, October 23rd. The medical instruments supplier reported $1.92 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.90 by $0.02. Waters had a net margin of 2.32% and a return on equity of 30.68%. The firm had revenue of $578.02 million for the quarter, compared to analyst estimates of $587.43 million. During the same period in the prior year, the firm earned $1.77 earnings per share. The business’s quarterly revenue was up 2.2% compared to the same quarter last year. Analysts anticipate that Waters Co. will post 8.05 EPS for the current year.

WARNING: “Waters Co. (WAT) Holdings Lifted by Jefferies Group LLC” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/waters-co-wat-holdings-lifted-by-jefferies-group-llc/2670907.html.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: What is the Ex-Dividend Date in Investing?

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.